Ursodiol protects the liver by replacing toxic bile acids with a gentler, non-toxic form. This shifts the chemical balance inside liver cells, reducing inflammation, preventing cell death, and improving the flow of bile out of the liver. It’s prescribed for several liver and gallbladder conditions, and for most people it works gradually over weeks to months.
How Ursodiol Changes Your Bile
Your liver produces bile acids to help digest fats. Most of these bile acids are hydrophobic, meaning they repel water. In a healthy liver, that’s fine because bile flows freely into the intestine. But when bile flow is blocked or sluggish (a condition called cholestasis), those hydrophobic bile acids build up inside liver cells and become toxic. They damage cell membranes and trigger inflammation.
Ursodiol is a naturally occurring bile acid that’s hydrophilic, meaning it mixes easily with water. When you take it daily, it gradually makes up a larger share of your total bile acid pool. This dilutes the concentration of the harsher bile acids, reducing their ability to damage liver cells. It also stimulates bile flow, helping clear the backlog. The net effect is less chemical stress on liver tissue.
Protecting Liver Cells From Damage
Beyond simply diluting toxic bile acids, ursodiol actively protects liver cells from dying. In cholestatic conditions, accumulated bile acids trigger a self-destruct process in liver cells called apoptosis. Ursodiol interrupts this process at the mitochondrial level, the cell’s energy center, blocking the chain of signals that would otherwise cause the cell to break apart. It also stabilizes certain protective proteins inside cells that act as a brake on inflammation and cell death.
This protective effect is one reason ursodiol consistently lowers liver enzyme levels. A large meta-analysis of randomized controlled trials found that ursodiol treatment significantly reduced all major liver enzymes, including ALT (down about 15 U/L on average), AST (down about 16 U/L), GGT (down about 23 U/L), and alkaline phosphatase (down about 94 U/L). Bilirubin levels also dropped. These improvements were seen across treatment periods ranging from one month to three years, though longer treatment showed greater reductions in some markers.
Primary Biliary Cholangitis
The condition where ursodiol has the strongest track record is primary biliary cholangitis (PBC), an autoimmune disease where the immune system slowly destroys the small bile ducts inside the liver. Without treatment, bile backs up, damages liver tissue, and can eventually lead to cirrhosis and liver failure.
Ursodiol is the standard first-line treatment for PBC at a dose of 13 to 15 mg per kilogram of body weight daily, split into two to four doses. It improves cholestatic markers and, more importantly, extends transplant-free survival. Even patients who don’t achieve a complete biochemical response (meaning their lab values don’t fully normalize) still benefit from treatment. For many people with PBC, ursodiol is a lifelong medication that slows or halts disease progression.
Dissolving Gallstones
Ursodiol can dissolve cholesterol gallstones, though it works best on small ones. For stones under 5 mm, about 90% of patients see complete dissolution within six months. Larger or multiple stones are harder to treat: the success rate drops to 40% to 50% after a full year of therapy. Stones larger than 10 mm rarely respond well. The typical dose for gallstone dissolution is 8 to 10 mg per kilogram of body weight daily.
This approach is generally reserved for people who can’t have surgery or who have small, uncomplicated stones. Gallstones can recur after ursodiol is stopped, so some people stay on it long-term as prevention, particularly after weight-loss surgery, which sharply increases gallstone risk.
Where Ursodiol Falls Short
Not every liver condition responds to ursodiol. In primary sclerosing cholangitis (PSC), a disease that scars and narrows the bile ducts, high-dose ursodiol actually made outcomes worse in a major clinical trial. Patients taking high doses were 2.3 times more likely to reach a serious endpoint like death, liver transplant, or advanced disease compared to those on placebo. Serious adverse events occurred in 63% of the high-dose group versus 37% on placebo. While ursodiol did improve liver test numbers in PSC patients, better lab values didn’t translate to better health. Current guidelines recommend against using high-dose ursodiol for PSC.
Ursodiol is also commonly prescribed for intrahepatic cholestasis of pregnancy, a condition that causes intense itching in the third trimester and raises the risk of complications for the baby. However, a large randomized trial published in The Lancet found that ursodiol did not significantly reduce adverse outcomes like preterm delivery, neonatal unit admission, or perinatal death compared to placebo. Adverse outcomes occurred in 23% of babies in the ursodiol group versus 27% in the placebo group, a difference that was not statistically significant.
Side Effects and What to Expect
Ursodiol is well tolerated by most people. The most common side effect is loose stools or diarrhea, which occurs in roughly 2% to 9% of patients. This tends to be mild and often improves as your body adjusts. Some people report minor digestive discomfort like nausea or bloating, but serious side effects are uncommon at standard doses.
Improvements in liver enzyme levels can begin within the first few months, but the full benefit of ursodiol builds over time. For PBC, response is typically assessed after about a year of treatment. For gallstone dissolution, you may need six months to a year of consistent use before imaging shows meaningful changes. Ursodiol needs to be taken with food to be absorbed properly, and sticking to a regular schedule matters because its effect depends on maintaining a steady presence in your bile acid pool.